Karuna Therapeutics, Inc. Annual Nonoperating Income (Expense) in USD from 2018 to 2023

Taxonomy & unit
us-gaap: USD
Description
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
Summary
Karuna Therapeutics, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from 2018 to 2023.
  • Karuna Therapeutics, Inc. Nonoperating Income (Expense) for the quarter ending December 31, 2023 was $16.4M, a 69.2% increase year-over-year.
  • Karuna Therapeutics, Inc. Nonoperating Income (Expense) for the twelve months ending December 31, 2023 was $61.8M, a 319% increase year-over-year.
  • Karuna Therapeutics, Inc. annual Nonoperating Income (Expense) for 2023 was $61.8M, a 319% increase from 2022.
  • Karuna Therapeutics, Inc. annual Nonoperating Income (Expense) for 2022 was $14.8M, a 27230% increase from 2021.
  • Karuna Therapeutics, Inc. annual Nonoperating Income (Expense) for 2021 was $54K, a 98.4% decline from 2020.
Nonoperating Income (Expense), Trailing 12 Months (USD)
Nonoperating Income (Expense), Annual (USD)
Nonoperating Income (Expense), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $61.8M +$47M +319% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-22
2022 $14.8M +$14.7M +27230% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-22
2021 $54K -$3.25M -98.4% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-22
2020 $3.31M +$1.86M +128% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-23
2019 $1.45M +$4.45M Jan 1, 2019 Dec 31, 2019 10-K 2022-02-24
2018 -$3M Jan 1, 2018 Dec 31, 2018 10-K 2021-02-25
* An asterisk sign (*) next to the value indicates that the value is likely invalid.